BIT 0.00% 1.9¢ biotron limited

From the last Q "The Company understands the high level of...

  1. 8,013 Posts.
    lightbulb Created with Sketch. 551
    From the last Q

    "The Company understands the high level of interest of shareholders in the outcomes of the completed clinical trials. Trials such as BIT225-011 that include longitudinal analyses of a multitude of immunological markers involve complex, time-consuming modeling and consultation with relevant experts. Good progress is being made and the Company looks forward to reporting results during the second quarter of 2024."

    It's what I am waiting for anyway.

    Although I am of course aware that "the coming weeks" was the original target about 9 months ago.

    EB
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $17.14M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $710 37.38K

Buyers (Bids)

No. Vol. Price($)
11 1609665 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 80000 1
View Market Depth
Last trade - 10.53am 12/11/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.